Related references
Note: Only part of the references are listed.Genetics of idiopathic pulmonary fibrosis: from mechanistic pathways to personalised medicine
Paolo Spagnolo et al.
JOURNAL OF MEDICAL GENETICS (2017)
Idiopathic Pulmonary Fibrosis: Current Status, Recent Progress, and Emerging Targets
Yi-Min Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Oligonucleotide Therapy for Obstructive and Restrictive Respiratory Diseases
Wupeng Liao et al.
MOLECULES (2017)
Is personalised medicine the key to heterogeneity in idiopathic pulmonary fibrosis?
Deborah L. Clarke et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Great expectations for simtuzumab in IPF fall short
Keith C. Meyer
LANCET RESPIRATORY MEDICINE (2017)
Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis
Robert Brownell et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Novel Mechanisms for the Antifibrotic Action of Nintedanib
Sunad Rangarajan et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2016)
Molecular Endotyping of Pulmonary Fibrosis
Amanda T. Goodwin et al.
CHEST (2016)
Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis
Michael Kreuter et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis
Ganesh Raghu et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy
Bernt van den Blink et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
IDIOPATHIC PULMONARY FIBROSIS: A GENETIC DISEASE THAT INVOLVES MUCOCILIARY DYSFUNCTION OF THE PERIPHERAL AIRWAYS
Christopher M. Evans et al.
PHYSIOLOGICAL REVIEWS (2016)
Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis
Paola Rogliani et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2016)
Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF
Paul F. Mercer et al.
THORAX (2016)
Novel drug targets for idiopathic pulmonary fibrosis
Giacomo Sgalla et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2016)
Dasatinib Reduces Lung Inflammation and Fibrosis in Acute Experimental Silicosis
Fernanda Ferreira Cruz et al.
PLOS ONE (2016)
TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis
Justin M. Oldham et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis An Update of the 2011 Clinical Practice Guideline
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Idiopathic pulmonary fibrosis: tracking the true occurrence is challenging
Jonathan M. Samet et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
Lutz Wollin et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
alpha v beta 6 integrin may be a potential prognostic biomarker in interstitial lung disease
Gauri Saini et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Dasatinib attenuated bleomycin-induced pulmonary fibrosis in mice
Oznur Yilmaz et al.
GROWTH FACTORS (2015)
Rapamycin increases CCN2 expression of lung fibroblasts via phosphoinositide 3-kinase
Xuefeng Xu et al.
LABORATORY INVESTIGATION (2015)
Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumonias
Antonio Morais et al.
RESPIRATORY MEDICINE (2015)
Precision medicine: Beyond the infection point
Sam Hawgood et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
Nicola A. Hanania et al.
THORAX (2015)
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study
R. Gisli Jenkins et al.
LANCET RESPIRATORY MEDICINE (2015)
Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis
Daryle J. DePianto et al.
THORAX (2015)
Serum level of periostin can predict long-term outcome of idiopathic pulmonary fibrosis
Morihiro Tajiri et al.
RESPIRATORY INVESTIGATION (2015)
The Role of Bacteria in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis
Phillip L. Molyneaux et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
C-X-C Motif Chemokine 13 (CXCL13) Is a Prognostic Biomarker of Idiopathic Pulmonary Fibrosis
Louis J. Vuga et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Targeting Interleukin-13 with Tralokinumab Attenuates Lung Fibrosis and Epithelial Damage in a Humanized SCID Idiopathic Pulmonary Fibrosis Model
Lynne A. Murray et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2014)
Fibulin-1 Predicts Disease Progression in Patients With Idiopathic Pulmonary Fibrosis
Jade Jaffer et al.
CHEST (2014)
MicroRNA mimicry blocks pulmonary fibrosis
Rusty L. Montgomery et al.
EMBO MOLECULAR MEDICINE (2014)
Transforming Growth Factor-β1 Downregulates Vascular Endothelial Growth Factor-D Expression in Human Lung Fibroblasts via the Jun NH2-Terminal Kinase Signaling Pathway
Ye Cui et al.
MOLECULAR MEDICINE (2014)
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism
Alexandra Zanin-Zhorov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Rituximab in severe, treatment-refractory interstitial lung disease
Gregory J. Keir et al.
RESPIROLOGY (2014)
Presence of a prothrombotic state in people with idiopathic pulmonary fibrosis: a population-based case-control study
Vidya Navaratnam et al.
THORAX (2014)
Effects of smoking, gender and occupational exposure on the risk of severe pulmonary fibrosis: a population-based case-control study
Magnus Ekstrom et al.
BMJ OPEN (2014)
Selective ROCK2 inhibition in focal cerebral ischemia
Jeong Hyun Lee et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
Promising new treatment targets in patients with fibrosing lung disorders
Martina Sterclova et al.
WORLD JOURNAL OF CLINICAL CASES (2014)
Differential diagnosis of usual interstitial pneumonia: when is it truly idiopathic?
Wim A. Wuyts et al.
EUROPEAN RESPIRATORY REVIEW (2014)
Targeted therapy for lung cancer: present and future
Charu Aggarwal
ANNALS OF PALLIATIVE MEDICINE (2014)
Antifibrotic and Anti-inflammatory Activity of the Tyrosine Kinase Inhibitor Nintedanib in Experimental Models of Lung Fibrosis
Lutz Wollin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Fibroblasts and myofibroblasts in wound healing
Ian A. Darby et al.
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2014)
Patients with Idiopathic Pulmonary Fibrosis with Antibodies to Heat Shock Protein 70 Have Poor Prognoses
Rehan A. Kahloon et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
The Toll-like Receptor 3 L412F Polymorphism and Disease Progression in Idiopathic Pulmonary Fibrosis
David N. O'Dwyer et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Animal Models of Fibrotic Lung Disease
Bethany B. Moore et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
Lysophosphatidic Acid Receptor-2 Deficiency Confers Protection against Bleomycin-Induced Lung Injury and Fibrosis in Mice
Long Shuang Huang et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
Oxidative stress and pulmonary fibrosis
Paul Cheresh et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Blood Biomarkers MMP-7 and SP-A Predictors of Outcome in Idiopathic Pulmonary Fibrosis
Jin Woo Song et al.
CHEST (2013)
Prevalence and prognosis of unclassifiable interstitial lung disease
Christopher J. Ryerson et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
A Phase One, Open Label, Multi-Dose Study To Evaluate the Safety, Tolerability, and Biologic Effects of Three Doses of IW001 in Patients with Idiopathic Pulmonary Fibrosis (IPF)
K. Rothhaar et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2013)
The Idiopathic Pulmonary Fibrosis Honeycomb Cyst Contains A Mucocilary Pseudostratified Epithelium
Max A. Seibold et al.
PLOS ONE (2013)
Type V Collagen Induced Tolerance Suppresses Collagen Deposition, TGF-β and Associated Transcripts in Pulmonary Fibrosis
Ragini Vittal et al.
PLOS ONE (2013)
Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis
M. R. Dillingh et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2013)
Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study
Imre Noth et al.
LANCET RESPIRATORY MEDICINE (2013)
A review of current and novel therapies for idiopathic pulmonary fibrosis
Rokhsara Rafii et al.
JOURNAL OF THORACIC DISEASE (2013)
Recent Advances in Idiopathic Pulmonary Fibrosis
Sanghoon Park et al.
TUBERCULOSIS AND RESPIRATORY DISEASES (2013)
Participation of miR-200 in Pulmonary Fibrosis
Shanzhong Yang et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Regulation of Transforming Growth Factor-β1-driven Lung Fibrosis by Galectin-3
Alison C. MacKinnon et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Peripheral Blood Proteins Predict Mortality in Idiopathic Pulmonary Fibrosis
Thomas J. Richards et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
4-Phenylbutyric Acid Treatment Rescues Trafficking and Processing of a Mutant Surfactant Protein-C
Gareth A. Stewart et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)
Delivery and Safety of Inhaled Interferon-γ in Idiopathic Pulmonary Fibrosis
Keith T. Diaz et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2012)
The distribution of immunomodulatory cells in the lungs of patients with idiopathic pulmonary fibrosis
Gerard J. Nuovo et al.
MODERN PATHOLOGY (2012)
Idiopathic pulmonary fibrosis: new evidence and an improved standard of care in 2012
Ganesh Raghu
LANCET (2012)
Prednisone, Azathioprine, and N-Acetylcysteine for Pulmonary Fibrosis
Ganesh Raghu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Correlation between circulating fibrocytes, and activity and progression of interstitial lung diseases
Atsushi Fujiwara et al.
RESPIROLOGY (2012)
Fibrocytes and the pathogenesis of diffuse parenchymal lung disease
Borna Mehrad et al.
FIBROGENESIS & TISSUE REPAIR (2012)
Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature
Luba Nalysnyk et al.
EUROPEAN RESPIRATORY REVIEW (2012)
Identification of Periplakin as a New Target for Autoreactivity in Idiopathic Pulmonary Fibrosis
Camille Taille et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Antiinflammatory and Antifibrotic Effects of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate in a Murine Model of Interstitial Lung Disease
Galina S. Bogatkevich et al.
ARTHRITIS AND RHEUMATISM (2011)
Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias
M. Okamoto et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
SERIES MATRIX METALLOPROTEINASES IN LUNG HEALTH AND DISEASE Metalloproteinases in idiopathic pulmonary fibrosis
R. C. A. Dancer et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P
Lynne A. Murray et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
Idiopathic pulmonary fibrosis
Talmadge E. King et al.
LANCET (2011)
Gateways to clinical trials
A. Tomillero et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2011)
A Common MUC5B Promoter Polymorphism and Pulmonary Fibrosis
Max A. Seibold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A novel single-chain-Fv antibody against connective tissue growth factor attenuates bleomycin-induced pulmonary fibrosis in mice
Xihua Wang et al.
RESPIROLOGY (2011)
Cooperative interaction of CTGF and TGF-beta in animal models of fibrotic disease
Qingjian Wang et al.
FIBROGENESIS & TISSUE REPAIR (2011)
Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis
Harold R. Collard et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2010)
Selective Expression of Connective Tissue Growth Factor in Fibroblasts In Vivo Promotes Systemic Tissue Fibrosis
Sonali Sonnylal et al.
ARTHRITIS AND RHEUMATISM (2010)
A novel, orally active LPA1 receptor antagonist inhibits lung fibrosis in the mouse bleomycin model
J. S. Swaney et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment
Vivian Barry-Hamilton et al.
NATURE MEDICINE (2010)
Fibulin-1 Is Increased in Asthma - A Novel Mediator of Airway Remodeling?
Justine Y. Lau et al.
PLOS ONE (2010)
Global Impairment of CD4+CD25+FOXP3+ Regulatory T Cells in Idiopathic Pulmonary Fibrosis
Ioannis Kotsianidis et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Serum CC-Chemokine Ligand 18 Concentration Predicts Outcome in Idiopathic Pulmonary Fibrosis
Antje Prassel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis
Antje Moeller et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Dabigatran, a Direct Thrombin Inhibitor, Demonstrates Antifibrotic Effects on Lung Fibroblasts
Galina S. Bogatkevich et al.
ARTHRITIS AND RHEUMATISM (2009)
Role of integrin-mediated TGFβ activation in the pathogenesis of pulmonary fibrosis
Amanda Goodwin et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2009)
The multifaceted role of periostin in tumorigenesis
Kai Ruan et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Interleukin-13 and Its Receptors in Idiopathic Interstitial Pneumonia: Clinical Implications for Lung Function
Sung-Woo Park et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2009)
Pulmonary fibrosis: pathogenesis, etiology and regulation
M. S. Wilson et al.
MUCOSAL IMMUNOLOGY (2009)
Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease?
Andrew Leask et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2009)
Partial inhibition of integrin alpha v beta 6 prevents pulmonary fibrosis without exacerbating inflammation
Gerald S. Horan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis
Benjamin D. Bringardner et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
BIBF 1120: Triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy
Frank Hilberg et al.
CANCER RESEARCH (2008)
Hyper-responsiveness of IPF/UIP fibroblasts: Interplay between TGF beta 1, IL-13 and CCL2
Lynne A. Murray et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Efeitos da quercetina na lesão pulmonar induzida por bleomicina: um estudo preliminar
José Antônio Baddini Martinez et al.
Jornal Brasileiro de Pneumologia (2008)
Short telomeres are a risk factor for idiopathic pulmonary fibrosis
Jonathan K. Alder et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis
Ivan O. Rosas et al.
PLOS MEDICINE (2008)
The lysophosphatidic acid receptor LPA(1) links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak
Andrew M. Tager et al.
NATURE MEDICINE (2008)
Myofibroblast contraction activates latent TGF-β1 from the extracellular matrix
Pierre-Jean Wipff et al.
JOURNAL OF CELL BIOLOGY (2007)
IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants
William J. Burlingham et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Regulation of fibroblast functions by lysophospholipid mediators: Potential roles in wound healing
Kenneth R. Watterson et al.
WOUND REPAIR AND REGENERATION (2007)
Cellular and humoral autoreactivity in idiopathic pulmonary fibrosis
Carol A. Feghali-Bostwick et al.
JOURNAL OF IMMUNOLOGY (2007)
Adult-onset pulmonary fibrosis caused by mutations in telomerase
Kalliopi D. Tsakiri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Telomerase mutations in families with idiopathic pulmonary fibrosis
Mary Y. Armanios et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Inflammatory cell phenotyping of the pulmonary interstitium in idiopathic interstitial pneumonia
Edwin Roger Parra et al.
RESPIRATION (2007)
Periostin: A novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals
Go Takayama et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Cutting edge:: Nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis
Joelle Marchal-Somme et al.
JOURNAL OF IMMUNOLOGY (2006)
A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18
A Prasse et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Overexpression of the ZIP1 zinc transporter induces an osteogenic phenotype in mesenchymal stem cells
ZH Tang et al.
BONE (2006)
Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis
M Selman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis -: art. no. 81
Z Daniil et al.
RESPIRATORY RESEARCH (2005)
Pirfenidone inhibits lung allograft fibrosis through L-arginine-arginase pathway
HZ Liu et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis
A Pardo et al.
PLOS MEDICINE (2005)
TGF-β signaling and the fibrotic response
A Leask et al.
FASEB JOURNAL (2004)
Protection from fluorescein isothiocyanate-induced fibrosis in IL-13-deficient, but not IL-4-deficient, mice results from impaired collagen synthesis by fibroblasts
JE Kolodsick et al.
JOURNAL OF IMMUNOLOGY (2004)
Regulation of found in inflammatory zone 1 expression in bleomycin-induced lung fibrosis: Role of IL-4/IL-13 and mediation via STAT-6
TJ Liu et al.
JOURNAL OF IMMUNOLOGY (2004)
Making sense of latent TGFβ activation
JP Annes et al.
JOURNAL OF CELL SCIENCE (2003)
Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis
JA Belperio et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)
Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans
FR Zuo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The integrin αvβ8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-β1
DZ Mu et al.
JOURNAL OF CELL BIOLOGY (2002)
Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival
DT Denhardt et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Role of osteopontin in the pathogenesis of bleomycin-induced pulmonary fibrosis
F Takahashi et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2001)
Share Paper
